2022
DOI: 10.3390/ijms23115978
|View full text |Cite
|
Sign up to set email alerts
|

Sedoheptulose Kinase SHPK Expression in Glioblastoma: Emerging Role of the Nonoxidative Pentose Phosphate Pathway in Tumor Proliferation

Abstract: Glioblastoma (GBM) is the most common form of malignant brain cancer and is considered the deadliest human cancer. Because of poor outcomes in this disease, there is an urgent need for progress in understanding the molecular mechanisms of GBM therapeutic resistance, as well as novel and innovative therapies for cancer prevention and treatment. The pentose phosphate pathway (PPP) is a metabolic pathway complementary to glycolysis, and several PPP enzymes have already been demonstrated as potential targets in ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 59 publications
0
5
0
1
Order By: Relevance
“…The top sensitive (with occurring times) aging, inflammatory and disease markers were also shown in Table 4 (Sarasin-Filipowicz et al, 2009 ; Chen and D'Mello, 2010 ; Malhotra et al, 2013 ; Charbit et al, 2015 ; An et al, 2017 ; Arentsen et al, 2017 ; Lee et al, 2018 ; Xiao et al, 2019 ; Sato et al, 2020 ; Peng et al, 2021 ; Franceschi et al, 2022 ; Saeidi et al, 2023 ). For example, the top aging and inflammatory markers were also TMPRSS13 and USP18, respectively.…”
Section: Resultsmentioning
confidence: 92%
See 1 more Smart Citation
“…The top sensitive (with occurring times) aging, inflammatory and disease markers were also shown in Table 4 (Sarasin-Filipowicz et al, 2009 ; Chen and D'Mello, 2010 ; Malhotra et al, 2013 ; Charbit et al, 2015 ; An et al, 2017 ; Arentsen et al, 2017 ; Lee et al, 2018 ; Xiao et al, 2019 ; Sato et al, 2020 ; Peng et al, 2021 ; Franceschi et al, 2022 ; Saeidi et al, 2023 ). For example, the top aging and inflammatory markers were also TMPRSS13 and USP18, respectively.…”
Section: Resultsmentioning
confidence: 92%
“…The Markov Chain Monte Carlo (MCMC) method was used to assess the sensitivity indices between inflammaging and MS. As a result, the 35 sensitive triples (by calculating the absolute difference frequency) were shown in Table 3 (Sarasin-Filipowicz et al, 2009 ; Chen and D'Mello, 2010 ; Bergbold and Lemberg, 2013 ; Liu et al, 2013 ; Malhotra et al, 2013 ; Wan, 2014 ; Charbit et al, 2015 ; Fusco et al, 2015 ; An et al, 2017 ; Arentsen et al, 2017 ; Maridas et al, 2017 ; Mathur et al, 2017 ; Xiao et al, 2019 ; Immler et al, 2020 ; Sato et al, 2020 ; Tong et al, 2020 ; Buhelt et al, 2021 ; Correale, 2021 ; Fadul et al, 2021 ; Ma et al, 2021 ; Peng et al, 2021 ; Bogacka et al, 2022 ; Franceschi et al, 2022 ; Hjæresen et al, 2022 ; Khurana and Goswami, 2022 ; Liu S. et al, 2022 ; Schebb et al, 2022 ; Watanabe et al, 2022 ; Saeidi et al, 2023 ). For example, the sensitive triple with maximum difference was “TMPRSS13-USP18-DCHS2” (the absolute difference value was 0.270469).…”
Section: Resultsmentioning
confidence: 99%
“…On the other hand, as depicted in Figure 4a, nine identified amplification driver genes by NBDep are in the IntOGen gene list, namely ERBB2, CDK4, FLT3, MAP2K1, KRAS, NRAS, GNAS, RUNX1 as oncogenes and LATS2 as a tumor suppressor. Additionally, other amplification driver genes identified by NBDep, such as ITGAE, ALKBH3, SHPK, and GJB3 have been previously reported to play a significant role in cancer [36][37][38][39]. NBDep also identified 23 non-missense driver genes that were previously reported in IntOGen, namely SIN3A, NTRK1, FN1, MGA, MAP3K1, PTEN, DROSHA, WRN, RELA, CDX2, KDR, CDKN1B, POLD1, PIK3R1, NUP214, PML, GATA3, TOP2A, APC, TP53, RAD21, GNAI2, and NXF1.…”
Section: Pan-cancer Analysismentioning
confidence: 99%
“…The end of определена в каждом образце по визyaльнo-аналоговой шкале, согласно S. Franceschi и соавт. [20]: в образце рассчитывали процент ядер клеток с различной интенсивностью окраски (3 балла -сильная, 2 баллаумеренная и 1 балл -слабая). Поскольку во всех группах ядерная экспрессия GR была практически тотальной и различалась только по интенсивности окрашивания клеточных ядер, после полуколичественной оценки экспрессии по 3-балльной шкале каждое животное во всех группах было отнесено к одному из 3 паттернов фенотипа, которые расценивались как высокий, умеренный и низкий.…”
Section: нейроканunclassified